Schedule of Diluted Net Income (Loss) Per Share (Details) - shares		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents		5,681,364	4,651,206
Convertible Debt Securities [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents	[1]		540,206
Common Stock Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents		5,648,563	473,609
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents	[2]	6,801	3,401
Series A Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents	[3]	26,000	26,000
Series C Convertible Preferred Stock[Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents	[4]		3,607,990

[1] - conversion prices variable

[2] - weighted average exercise price - $16/share and $16/share, respectively

[3] - each share converts to 1/10 of a share of common stock

[4] - each share converts to 250 shares of common stock